A detailed history of Signaturefd, LLC transactions in Biocryst Pharmaceuticals Inc stock. As of the latest transaction made, Signaturefd, LLC holds 6,305 shares of BCRX stock, worth $47,224. This represents 0.0% of its overall portfolio holdings.

Number of Shares
6,305
Previous 6,598 4.44%
Holding current value
$47,224
Previous $40,000 17.5%
% of portfolio
0.0%
Previous 0.0%

Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 21, 2024

SELL
$6.41 - $8.69 $1,878 - $2,546
-293 Reduced 4.44%
6,305 $47,000
Q2 2024

Jul 29, 2024

BUY
$4.13 - $6.79 $23,123 - $38,017
5,599 Added 560.46%
6,598 $40,000
Q1 2024

May 03, 2024

SELL
$4.89 - $7.65 $3,344 - $5,232
-684 Reduced 40.64%
999 $5,000
Q4 2023

Jan 31, 2024

BUY
$4.98 - $6.77 $4,531 - $6,160
910 Added 117.72%
1,683 $10,000
Q3 2023

Nov 03, 2023

BUY
$6.71 - $7.92 $5,186 - $6,122
773 New
773 $5,000
Q1 2023

Apr 28, 2023

BUY
$7.94 - $11.84 $738 - $1,101
93 New
93 $0
Q3 2022

Nov 08, 2022

BUY
$10.79 - $14.81 $151 - $207
14 New
14 $0
Q2 2022

Aug 10, 2022

SELL
$7.89 - $17.88 $260 - $590
-33 Closed
0 $0
Q1 2022

May 02, 2022

BUY
$11.56 - $19.76 $381 - $652
33 New
33 $1,000

Others Institutions Holding BCRX

About BIOCRYST PHARMACEUTICALS INC


  • Ticker BCRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,944,992
  • Market Cap $1.39B
  • Description
  • BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...
More about BCRX
Track This Portfolio

Track Signaturefd, LLC Portfolio

Follow Signaturefd, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Signaturefd, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Signaturefd, LLC with notifications on news.